Can Adderall cause hair loss? Whilst Adderall itself is not licensed in the UK, closely related stimulant medications — including lisdexamfetamine (Elvanse) and methylphenidate — list alopecia as a rare or frequency-not-known adverse reaction in their UK prescribing information. The most likely mechanism is telogen effluvium, a temporary, diffuse form of hair shedding triggered by physiological stress rather than a direct effect on the hair follicle. This article explores the evidence, other contributing factors to consider, when to seek medical advice, and practical steps you can take whilst continuing your treatment.

Does Adderall Cause Hair Loss?

Adderall is not licensed in the UK, but equivalent stimulants list alopecia as a rare adverse reaction; the most likely mechanism is telogen effluvium rather than a confirmed direct causal effect.

Experiencing these side effects? Our pharmacists can help you navigate them →

Adderall is a brand-name stimulant medication containing mixed amphetamine salts, widely prescribed in the United States for attention deficit hyperactivity disorder (ADHD) and narcolepsy. Adderall itself is not licensed or routinely prescribed in the United Kingdom. In the UK, ADHD is typically managed with licensed stimulant medications such as methylphenidate (e.g., Ritalin, Concerta XL), lisdexamfetamine (Elvanse), or dexamfetamine (e.g., Amfexa) — the latter two sharing a similar pharmacological profile to Adderall.

Hair loss (alopecia) is listed as a rare or frequency-not-known adverse reaction in the Summary of Product Characteristics (SmPC) for UK-licensed stimulants including lisdexamfetamine (Elvanse) and methylphenidate, as documented on the electronic Medicines Compendium (emc, medicines.org.uk/emc). A possible association therefore exists, though a definitive causal relationship has not been established. Hair loss is not considered a common side effect, and many individuals taking these medicines do not experience it.

The condition most commonly associated with medication-related hair shedding is telogen effluvium — a temporary, diffuse form of hair loss triggered by physiological stress on the body. This can occur in response to a wide range of medications, nutritional changes, or systemic stressors. If you have noticed increased hair shedding after starting a stimulant medication, it is advisable to discuss this with your prescriber rather than stopping the medication abruptly, as doing so without medical supervision carries its own risks.

How Stimulant Medications May Affect Hair Growth

Stimulants may indirectly trigger telogen effluvium by suppressing appetite, disrupting sleep, and altering stress hormones, causing follicles to prematurely enter the shedding phase two to four months later.

To understand how stimulant medications might theoretically contribute to hair loss, it is helpful to consider their mechanism of action. Methylphenidate works primarily by inhibiting the reuptake of dopamine and noradrenaline, whilst amphetamine-based drugs such as lisdexamfetamine and dexamfetamine both inhibit reuptake and increase the release of these neurotransmitters. These central effects underpin their therapeutic benefit in ADHD.

Not sure if this is normal? Chat with one of our pharmacists →

However, stimulant medications also have peripheral effects on the body. They are known to:

• Suppress appetite, which can lead to reduced caloric and nutritional intake

• Increase heart rate and blood pressure, reflecting broader sympathomimetic activity

• Disrupt sleep patterns, particularly if taken later in the day

• Potentially cause small, transient increases in stress hormones in some individuals, though the evidence for this is limited and inconsistent

Each of these physiological changes can, in theory, place stress on the hair follicle cycle. Hair growth occurs in phases — anagen (growth), catagen (transition), and telogen (resting/shedding). When the body experiences significant physiological stress — whether from poor nutrition, sleep disruption, or hormonal fluctuation — a larger proportion of follicles may prematurely enter the telogen phase, resulting in diffuse shedding approximately two to four months later. This pattern is well described in guidance from the British Association of Dermatologists (BAD) on telogen effluvium.

It is therefore plausible that hair loss observed in some individuals taking stimulant medications may be indirectly related to these secondary effects rather than a direct pharmacological action on the hair follicle itself. This distinction is clinically important, as it suggests that addressing the underlying contributing factor — such as improving nutritional intake — may resolve the hair loss without requiring a change in medication.

Other Factors That Can Contribute to Hair Loss

Thyroid dysfunction, iron deficiency, androgenetic alopecia, and ADHD-related poor sleep or diet are common causes that must be excluded before attributing hair loss to stimulant medication.

When evaluating hair loss in someone taking stimulant medication, it is essential to consider the full clinical picture. Hair loss is a common complaint with a broad differential diagnosis, and attributing it solely to medication without investigation may result in an underlying condition being missed.

Common causes of hair loss that should be considered include:

• Androgenetic alopecia (male or female pattern hair loss) — the most prevalent cause, driven by genetic and hormonal factors

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning

• Iron deficiency — particularly common in women of reproductive age; ferritin is the most sensitive marker

• Alopecia areata — an autoimmune condition causing patchy hair loss

• Polycystic ovary syndrome (PCOS) — associated with androgen-driven hair thinning in women

• Significant psychological stress or anxiety — which may itself be related to undertreated ADHD

• Traction alopecia or trichotillomania — hair loss related to physical tension on the hair or compulsive pulling

It is also worth noting that ADHD is frequently associated with irregular eating habits, poor sleep, and heightened stress responses — all of which are independent risk factors for telogen effluvium. In some cases, hair loss may predate the medication or be related to the condition itself rather than its treatment.

A thorough assessment by a GP should include a detailed medication and dietary history, alongside targeted blood tests. In UK primary care, first-line investigations typically include a full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH). Further tests — such as B12/folate, coeliac screen, or androgen levels in women with signs of hyperandrogenism — are ordered only when clinically indicated. Routine testing or supplementation for zinc, vitamin D, or biotin is not recommended without a specific clinical indication; biotin deficiency is rare, and high-dose biotin supplementation can interfere with certain laboratory assays.

Red flags that should prompt prompt GP review and possible urgent dermatology referral include scalp pain, redness, scaling, pustules, or any features suggesting scarring alopecia, as scarring forms of hair loss can cause permanent follicle damage if not treated early. NICE Clinical Knowledge Summaries (CKS) and the Primary Care Dermatology Society (PCDS) provide UK-specific guidance on the assessment and investigation of hair loss in primary care.

When to Speak to Your GP or Prescriber

See your GP if hair loss is rapid, patchy, or accompanied by scalp changes, systemic symptoms, or significant distress — and never stop stimulant medication abruptly without medical advice.

If you have noticed hair thinning or increased shedding since starting a stimulant medication, it is reasonable to raise this with your GP or prescribing clinician. Whilst hair loss is rarely a medically urgent concern, there are circumstances in which prompt assessment is warranted.

You should contact your GP if:

• Hair loss is rapid, extensive, or accompanied by bald patches

• You notice scalp pain, redness, scaling, or pustules — these may indicate a scarring or inflammatory condition requiring prompt dermatology assessment

• You are experiencing other new symptoms such as fatigue, weight changes, or skin changes that may suggest an underlying systemic condition

• Hair loss is causing significant psychological distress

• You have noticed changes in appetite or weight since starting medication that may indicate nutritional deficiency

• You are unsure whether to continue your medication

It is important not to stop stimulant medication abruptly without speaking to your prescriber first. Doing so can lead to a rebound of ADHD symptoms and possible discontinuation symptoms, including fatigue, low mood, and difficulty concentrating. Your prescriber can help weigh the benefits and risks, consider whether a dose adjustment is appropriate, or explore alternative medications if necessary.

In the UK, stimulant medications for ADHD are typically initiated and monitored by a specialist (psychiatrist or paediatrician), with ongoing prescribing often shared with a GP under a shared care agreement. Both your specialist and GP are appropriate points of contact for concerns about side effects. Keeping a symptom diary — noting when hair loss began relative to medication changes — can be a helpful tool to bring to your appointment. The NHS hair loss (alopecia) page provides accessible guidance on when to seek GP review.

Managing Hair Loss Whilst Taking Medication

Addressing nutritional deficiencies, optimising dose timing to protect sleep, and minimising mechanical hair stress are first-line strategies; topical minoxidil for telogen effluvium is off-label and requires GP discussion.

For individuals who suspect their hair loss may be related to stimulant medication, there are several practical strategies that may help, many of which address the indirect mechanisms discussed earlier.

Nutritional support is often a key consideration. Stimulant medications are well known to suppress appetite, and inadequate intake of protein, iron, and essential nutrients can impair hair follicle function. Practical steps include:

• Eating a nutritious meal before taking medication, when appetite is naturally stronger

• Incorporating protein-rich foods (eggs, legumes, lean meat, dairy) into daily meals

• Discussing supplementation with a GP if blood tests confirm a specific deficiency — avoid high-dose supplements without confirmed deficiency, as these are unlikely to help and some (such as high-dose biotin) can interfere with laboratory tests

• Avoiding highly restrictive diets whilst on stimulant therapy

• Seeking dietetic input if appetite suppression is significantly affecting nutritional intake

Sleep hygiene is equally important. Taking stimulant medication too late in the day can interfere with sleep, and chronic sleep deprivation is a recognised trigger for telogen effluvium. Reviewing the timing of doses with your prescriber may help.

From a hair care perspective, minimising mechanical stress on the hair — such as avoiding tight hairstyles, excessive heat styling, and harsh chemical treatments — can reduce additional shedding during a vulnerable period.

Topical minoxidil is licensed in the UK for androgenetic alopecia (male and female pattern hair loss). Its use in telogen effluvium is off-label and the evidence base is limited; it should only be considered after discussion with a GP or dermatologist, who can confirm the diagnosis and advise on suitability. The emc SmPC for topical minoxidil provides full prescribing information.

If hair loss persists or is causing significant distress, your GP can refer you to a NHS dermatologist for specialist assessment and management. Some individuals also consult private trichologists; however, it is important to be aware that trichology is not a statutorily regulated profession in the UK, and a dermatologist remains the appropriate specialist for diagnosis and treatment of hair loss conditions.

If stimulant-related side effects — including appetite suppression or sleep disturbance — are difficult to manage, your specialist may consider dose adjustment or a switch to a non-stimulant ADHD medication such as atomoxetine or guanfacine, which do not carry the same appetite-suppressing effects.

In most cases of telogen effluvium, hair regrowth occurs naturally once the triggering factor is resolved. Visible improvement may take three to six months due to the natural hair growth cycle. The BAD and PCDS provide patient-facing information on telogen effluvium and expected recovery.

MHRA Guidance and Reporting Side Effects in the UK

Suspected side effects from UK-licensed stimulants should be reported via the MHRA Yellow Card scheme; the emc SmPC for each medicine lists all known adverse reactions including hair loss.

The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK body responsible for ensuring that medicines and medical devices are safe and effective. The MHRA continuously monitors the safety of licensed medicines through a post-marketing surveillance system, which relies in part on reports submitted by both healthcare professionals and members of the public.

In the UK, suspected side effects from any medication — including stimulants such as lisdexamfetamine (Elvanse) and methylphenidate — can be reported via the Yellow Card scheme, accessible online at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting a suspected side effect does not confirm that the medication caused it; rather, it contributes to the evidence base that allows the MHRA to identify potential safety signals and update prescribing guidance where necessary. Healthcare professionals are encouraged to report any unexpected or serious adverse reactions, whilst patients and carers are equally welcome to submit reports directly.

For the most up-to-date prescribing information and listed adverse reactions for any UK-licensed medicine, the emc (medicines.org.uk/emc) provides the approved SmPC for each product, including Section 4.8 (Undesirable effects). If you have concerns about a specific medication, your pharmacist is an accessible and knowledgeable resource who can review your full medication list, identify potential interactions or side effects, and advise on when onward referral to a GP or specialist is appropriate.

Frequently Asked Questions